Search results

Selected filters:

Law & Policy

Article type

Topic

Sector

Regions

2,770 results found for your search

Sort options
12 April 2019

Controversial EPO patentability intervention is unlikely to succeed, experts claim

Attorneys say agency’s president has no legal basis for asking the Enlarged Board of Appeal to review the finding that plants produced by biological processes are patentable.

11 April 2019

One year on from the<em> SAS </em>decision practitioners mull its impact on the PTAB

In a period of marked change at the board, early numbers suggest the Supreme Court’s landmark decision is leading to greater discretion among petitioners

09 April 2019

'Reverse patent trolls' plague big pharma in China

The high invalidation rate for life science patents in China has created a headache for drug companies and a money-making opportunity for enterprising individuals

08 April 2019

The current cost of transparency in IoT patent licensing

Two senior members of the Ericsson IP team argue that innovators involved in wireless standardisation currently face impossible choices that lead to over-declaration or potential loss of enforceability

08 April 2019

Despite Iancu message to relook at Supreme Court precedent CAFC knocks out another medical diagnostics patent on 101

With outline of proposed subject matter eligibility bill expected this month latest key Federal Circuit ruling ratchets up the pressure on Congressional action  

08 April 2019

Reforms seek to boost South Korea's patent market

Firms welcomed tougher measures against infringers at IPBC Korea 2019 last week, but there are concerns about a recent initiative to attract more foreign litigants through the use of English-language hearings

06 April 2019

The big biopharma patent developments in March

Everything you need to know about the major news stories in the life sciences sector that broke last month

05 April 2019

UK Supreme Court confirms dosage regimens are patentable

Judges rule that inventions arrived at by well-established or routine tests can be patented, but the decision will also reassure generics

04 April 2019

Daimler's Nokia complaint may throw light on how EU SEP communication is working

German car giant brings complaint against Finnish company in effort to get clarification around licensing of mobile standard essential patents in the auto sector

03 April 2019

<em>IAM</em>’s Auto IP series taking place against a backdrop of major change

With so many issues emerging across the entire supply chain, the sector’s IP leaders will be sharing their thoughts and insights at events in Detroit and Munich next month

02 April 2019

Latest data adds weight to Iancu’s claim of a “new day” at the PTAB

Number of petitions slumps in the first quarter as petitioners and patent owners come to terms with 12 months of change at the board 

01 April 2019

Federal Circuit doubles down on ineligibility of diagnostic correlations

What the latest Federal Circuit 101 decision means for the medical diagnostics sector.

01 April 2019

Even as the storm clouds gather, Huawei’s enviable IP position means that it cannot be ignored in 5G

Storm clouds are gathering over the most talked about company in the telecoms sector but as we embark on a new era of mobile technology, Huawei still enjoys a number of notable advantages.

01 April 2019

Shenzhen implements tough new IP enforcement rules

Regulations in the special economic zone once known primarily as a den of piracy will allow fast-track administrative injunctions and impose stiff penalties on repeat infringers

31 March 2019

Charting China’s changing pharma patent landscape

China’s healthcare sector is booming and while the patent system has developed considerably in recent years, pharmaceutical companies should still think carefully about how to protect their rights.